0 false false false false false false true false false true false false false false true true No description of principal activity 2022-03-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 04263877 2022-03-01 2023-02-28 04263877 2023-02-28 04263877 2022-02-28 04263877 bus:Director1 2022-03-01 2023-02-28 04263877 core:WithinOneYear 2023-02-28 04263877 core:WithinOneYear 2022-02-28 04263877 core:AfterOneYear 2023-02-28 04263877 core:AfterOneYear 2022-02-28 04263877 core:RestatedAmount 2022-02-28 04263877 bus:Micro-entities 2022-03-01 2023-02-28 04263877 bus:AuditExempt-NoAccountantsReport 2022-03-01 2023-02-28 04263877 bus:FullAccounts 2022-03-01 2023-02-28 04263877 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 04263877 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28
COMPANY REGISTRATION NUMBER: 04263877
FOURTS EXPOPHARM (UK) LTD
Filleted Unaudited Financial Statements
28 February 2023
FOURTS EXPOPHARM (UK) LTD
Statement of Financial Position
28 February 2023
2023
2022
£
£
£
Fixed assets
11
11
----
----
Current assets
5
5
Creditors: amounts falling due within one year
77,241
77,241
--------
--------
Net current liabilities
77,236
77,236
--------
--------
Total assets less current liabilities
( 77,225)
( 77,225)
Creditors: amounts falling due after more than one year
13,000
13,000
Accruals and deferred income
150
150
--------
--------
(90,375)
(90,375)
--------
--------
Capital and reserves
( 90,375)
( 90,375)
--------
--------
Notes to the financial statements
1. Directors' advances, credits and guarantees
There were no advances and credits to or from the director .
2. Other spare note 99 heading
SPAREB99 USER DEFINED HEADING
The company.......
For the year ending 28 February 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 23 January 2024 , and are signed on behalf of the board by:
Mr Bowale Sotire
Director
Company registration number: 04263877
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 6 Greenwich Quay, Clarence Road, London, SE8 3EY.